Searching for your content...
Phone
877-269-7890 from 8 AM - 10 PM ET
Contact Cision
Approval is based on the Phase 3 KEYNOTE-811 Trial KIRKLAND, QC, Feb. 12, 2024 /CNW/ - Merck (NYSE: MRK), known as MSD outside the United States and...
MONTREAL, QC, Jan. 24, 2024 /CNW/ - Otsuka Pharmaceutical Canada Inc. (Otsuka) and Lundbeck Canada Inc. (Lundbeck) announce that Health Canada has...
Novavax, Inc. (Nasdaq: NVAX), a global company advancing protein-based vaccines with its Matrix-M™ adjuvant, today announced that Health Canada has...
Mounjaro delivered superior HbA1c reductions versus Ozempic (semaglutide) 1 mg in the phase 3 SURPASS-2 clinical trial While not indicated for weight ...
Ultomiris transforms the treatment landscape for AQP4 Ab+ NMOSD patients, with potential to eliminate relapses and improve outcomes MISSISSAUGA, ON,...
KIRKLAND, QC, and MISSISSAUGA, ON, Oct. 25, 2023 /CNW/ - Merck (NYSE: MRK), known as MSD outside the United States and Canada, and Eisai announced...
Sumitomo Pharma Canada, Inc. and Pfizer Canada today announced that Health Canada has granted a Notice of Compliance (NOC) for MYFEMBREE (Relugolix,...
MONTREAL, Oct. 17, 2023 /CNW/ - AbbVie (NYSE: ABBV), today announced that EPKINLY™ (epcoritamab injection/epcoritamab for injection) has received...
Dalan Animal Health, Inc. ("Dalan"), the pioneering biotech company specializing in insect health, today announced it has received market...
TORONTO, Oct. 13, 2023 /CNW/ - Geneseeq Technology Inc. announced on Thursday that Geneseeq's Non-Small Cell Lung Cancer Tumor Mutational Burden Test ...
Novavax, Inc. (Nasdaq: NVAX), a global company advancing protein-based vaccines with its novel Matrix-M™ adjuvant, today announced that the Novavax...
The updated vaccine (XBB.1.5 variant-adapted monovalent COVID-19 vaccine) is now authorized in Canada for individuals 6 months of age and older The...
Veteran to receive APEX-90 macrodose psilocybin drug product in combination with assisted psychotherapy consistent with SUMMIT-90 clinical trial...
Join PR Newswire for Journalists to access all of the free services designated to make your job easier.
In need of subject matter experts for your story? Submit a free ProfNet request and find the sources you need.